other material
confidence high
sentiment neutral
materiality 0.60
Immunome prices $200M follow-on offering of 10M shares at $20/share
Immunome Inc.
- Priced 10,000,000 common shares at $20.00 each; gross proceeds ~$200M before expenses.
- Underwriters have 30-day option to purchase up to 1,500,000 additional shares.
- Closing expected February 16, 2024, subject to customary conditions.
- Proceeds intended for general corporate purposes; J.P. Morgan, Cowen, Leerink, Guggenheim lead offering.